THE ROLE OF PLANT POLYPHENOLS IN THE HEALTH PRESERVATION: EFFECTS ON HUMAN CARDIOMETABOLIC FUNCTION

  • Miloš Gostimirović Institute for pharmacology, clinical pharmacology and toxicology, Medical Faculty, University of Belgrade
  • Jovana Rajkovic Institute of pharmacology, clinical pharmacology and toxicology
  • Vladimir Djokic Institut for pharmacology, clinical pharmacology and toxicology, Medical Faculty, University of Belgrade
  • Dusko Terzic Clinic for cardiosurgery, Clinical centre of Serbia
  • Svetozar Putnik Clinic for cardiosurgery, Clinical centre of Serbia
  • Ljiljana Gojkovic-Bukarica Institute for pharmacology, clinical pharmacology and toxicology, Medical faculty, University of Belgrade
Keywords: plant polyphenols, general biological properties, cardiovascular diseases, cardiometabolic effects

Abstract


Although the continuous improvement of diagnostic possibilities and the organizational structure of the Health system contributes to the reduction of the complicated courses of diseases, modern socio-economic and environmental stressors, life habits and increased fluctuation in the psychological functioning of the individual have a great influence on the overall burden of human diseases. Today, etiological factors and pathogenic mechanisms of many diseases are known, thus enabling their continuous and timely pharmacotherapy. However, for progressive diseases or those associated with the many complications, pharmacological treatment can lead to the side effects, so preventive measures are highlighted as the main strategy in the management of such diseases, especially in chronic non-communicable diseases such as cardiovascular diseases (CVDs). One of the preventive measures is timely and qualitative supplementation of the diet with beneficial micronutrients and oligoelements. Their main sources are represented in plant fibers that synthesize biologically active substances with a polyphenolic ring in their structure, called natural polyphenolic compounds (NPC). Decades of NPC research have brought new insights into the potential modification of existing pharmacotherapy of many diseases. Today, it is known that many polyphenols have an optimal pharmacological profile with cardioprotection and at the center of their overall effects. Research into the mechanisms of polyphenolic action is exhaustive, their interactions with numerous subcellular structures have been described, and they are refered as promising molecules, with the potential to modify key pathogenetic elements that lead to the progression of many diseases. So far, their numerous effects on endothelium, smooth muscle cells and lipid cells involved in the process of atherogenesis are known, their antidiabetic, antioxidant, anti-inflammatory and immunomodulatory properties have been proven, and the synergy with the intestinal microbial populations has recently been known to contribute to their beneficial effects. This paper has the aim to point out the most important mechanisms that NPC use to improve general functionality of the organism by stimulating its defense capacity, prolonging cell life and delaying the overall aging of the organism. As the most important cardioprotective nutrients, special focus is given to their beneficial effects on cardiovascular and metabolic function.

Author Biographies

Miloš Gostimirović, Institute for pharmacology, clinical pharmacology and toxicology, Medical Faculty, University of Belgrade

dr, istraživač-pripravnik

Jovana Rajkovic, Institute of pharmacology, clinical pharmacology and toxicology

molecular biologist, reaserch-associate

Vladimir Djokic, Institut for pharmacology, clinical pharmacology and toxicology, Medical Faculty, University of Belgrade

MD, PhD

Dusko Terzic, Clinic for cardiosurgery, Clinical centre of Serbia

clinical assistant

Svetozar Putnik, Clinic for cardiosurgery, Clinical centre of Serbia

full professor

Ljiljana Gojkovic-Bukarica, Institute for pharmacology, clinical pharmacology and toxicology, Medical faculty, University of Belgrade

full professor

References

1. World Health Organization. Global status report on non communicable diseases. Geneva: WHO; 2014.
2. K. Kario, Morning surge in blood pressure and cardiovascular risk: evidence and perspectives, Hypertension 56 (2010) 765–773.
3. Scalbert A, Manach C, Morand C, Remesy C. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005; 45:287–306.
4. Graf BA, Milbury PE, Blumberg JB. Flavonols, flavonones, flavanones and human health: Epidemological evidence. J Med Food. 2005; 8:281–290.
5. Claudine Manach, Augustin Scalbert, Christine Morand, Christian Rémésy, Liliana Jiménez, Polyphenols: food sources and bioavailability, The American Journal of Clinical Nutrition, Volume 79, Issue 5, May 2004, Pages 727–747.
6. Kanti Bhooshan Pandey, Syed Ibrahim Rizvi, "Plant Polyphenols as Dietary Antioxidants in Human Health and Disease", Oxidative Medicine and Cellular Longevity, vol. 2, Article ID 897484, 9 pages, 2009.
7. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007; 224:274–283.
8. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Ann Rev Nutr. 2001; 21:381–406.
9. Gerszon, J., Rodacka, A., & Puchała, M. (2014). Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases, Medical Journal of Cell Biology, 4(2), 97-117.
10. Ladiwala AR, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordcik JS, Tessier PM. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem. 2010; 285(31): 24228-24237.
11. Marabaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem. 2005; 280(45): 37377-37382.
12. Balcerczyk A, Pirola L. Therapeutic potential of activators and inhibitors of sirtuins. BioFactors. 2010; 36(5): 383-393.
13. Clark J, Silvagi JM, Kiselak T, Zheng K, Clore EL, Dai Y, Bas CE, Simon DK. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf. PLoS One. 2012; 7(11): e48925.
14. Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science. 2009; 323: 1063-1066.
15. Bouarab-Chibane L, Forquet V, Lantéri P, et al. Antibacterial Properties of Polyphenols: Characterization and QSAR (Quantitative Structure-Activity Relationship) Models. Front Microbiol. 2019; 10:829.
16. Xie Y, Chen J, Xiao A, Liu L. Antibacterial Activity of Polyphenols: Structure-Activity Relationship and Influence of Hyperglycemic Condition. Molecules. 2017; 22(11):1913.
17. Annunziata G, Sanduzzi Zamparelli M, Santoro C, et al. May Polyphenols Have a Role against Coronavirus Infection? An Overview of in vitro Evidence. Front Med (Lausanne). 2020; 7:240.
18. Min-Ho Oak, Cyril Auger, Eugenia Belcastro, Sin-Hee Park, Hyun-Ho Lee and Valérie B. Schini-Kerth, Potential mechanisms underlying cardiovascular protection by polyphenols: Role of the endothelium, Free Radical Biology and Medicine, Volume 122, 2018, pages 161-170.
19. W.F. Hodnick, W.J. Roettger, F.S. Kung, C.W. Bohmont, R.S. Pardini, Inhibition of mitochondrial respiration and production of superoxide and hydrogen peroxide by flavonoids: a structure activity study, Prog. Clin. Biol. Res. 213 (1986) 249–252.
20. M.O. Kane, N. Etienne-Selloum, S.V. Madeira, M. Sarr, A. Walter, S. Dal-Ros, C. Schott, T. Chataigneau, V.B. Schini-Kerth. Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols, Pflugers Arch. 459 (2010) 671–679.
21. J. Ka¨hler, A. Ewert, J. Weckmu¨ller, et al., Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells, J. Cardiovasc. Pharmacol. 38 (2001) 49–57.
22. Rahul V. Patel, Bhupendra M. Mistry, Surendra K. Shinde, Riyaz Syed, Vijay Singh, Han-Seung Shin, Therapeutic potential of quercetin as a cardiovascular agent, European Journal of Medicinal Chemistry, Volume 155, 2018, pages 889-904.
23. L.G. Bukarica, D. Protic, V. Kanjuh, H. Heinle, R. Novakovic, R. Scepanovic, Cardiovascular effects of resveratrol, Vojnosanit. Pregl. 70 (2013), pp. 1145-1150.
24. Rodrigo, R., Gil, D., Miranda-Merchak, A., & Kalantzidis, G. (2012). Antihypertensive Role of Polyphenols. Advances in Clinical Chemistry, 225–254.
25. Gojković-Bukarica, L.C., Kanjuh, V.I., Novaković, R.B. et al. The differential effect of resveratrol on the renal artery of normal and diabetic rats. BMC Pharmacol Toxicol 13, A48 (2012).
26. Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. Cocoa and cardiovascular health. Circulation. 2009; 119(10):1433-1441.
27. Kim, Y.; Keogh, J.B.; Clifton, P.M. Polyphenols and Glycemic Control. Nutrients 2016, 8, 17.
28. Van Dieren, S.; Uiterwaal, C.S.; van der Schouw, Y.T.; van der, A.D.; Boer, J.M.; Spijkerman, A.; Grobbee, D.E.; Beulens, J.W. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 2009, 52, 2561–2569.
29. Arnlov, J.; Vessby, B.; Riserus, U. Coffee consumption and insulin sensitivity. JAMA 2004, 291, 1199–1201.
Published
2021/04/26
Section
Mini pregledni članak